Trial Profile
Brain Derived Neurotrophic Factor as a Predictor of Response to Treatment in Bipolar Depression and Mania: 16-Weeks Follow-up With Quetiapine XR.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Bipolar I disorders; Mania
- Focus Pharmacogenomic; Therapeutic Use
- 16 Apr 2009 New trial record